The Truth About GLP-1 Peptides: Why Fitness and Nutrition Still Matter

GLP-1 receptor agonists—such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro)—have surged in popularity as potent tools for weight loss and metabolic health. These medications mimic the glucagon-like peptide-1 hormone, enhancing insulin secretion, suppressing appetite, and slowing gastric emptying. While their efficacy is well-documented, relying solely on these drugs without integrating fitness and nutrition strategies can undermine long-term success.(SELF, CU Anschutz News)

This article delves into seven critical insights about GLP-1 peptides, emphasizing the indispensable roles of exercise and balanced nutrition.

1. GLP-1s Promote Weight Loss, But Not Muscle Preservation

GLP-1 medications effectively reduce body weight. A meta-analysis of 47 randomized controlled trials found that GLP-1 receptor agonists led to an average weight reduction of 4.57 kg, a BMI decrease of 2.07 kg/m², and a waist circumference reduction of 4.55 cm compared to placebo .(PMC, Diabetes Journals)

However, this weight loss often includes lean muscle mass, which is vital for metabolic health and physical function. Without resistance training, individuals risk losing muscle, potentially leading to decreased strength and a slower metabolism .(CU Anschutz News, eucalyptus.health)

2. Exercise Enhances GLP-1 Efficacy

Combining GLP-1 therapy with regular exercise amplifies health benefits. A randomized controlled trial demonstrated that participants who engaged in both exercise and GLP-1 treatment experienced greater reductions in metabolic syndrome severity, abdominal fat, and inflammation markers compared to those using either intervention alone .(PMC, PubMed)

Moreover, endurance training has been shown to improve beta-cell sensitivity to GLP-1, enhancing glucose tolerance in overweight individuals .(PMC)

3. Discontinuation Often Leads to Weight Regain

While GLP-1s are effective during use, their benefits may diminish after cessation. An analysis presented at the European Congress on Obesity revealed that individuals who stopped GLP-1 treatments regained an average of 9.6 kg within a year, returning to their original weight .(Health, The Guardian)

This underscores the importance of sustainable lifestyle changes to maintain weight loss post-medication.(The Sun)

4. Nutrition Is Crucial for Sustained Success

A balanced diet complements GLP-1 therapy by supporting muscle preservation and overall health. Adequate protein intake, for instance, is essential for muscle maintenance during weight loss. Studies suggest consuming 1.2 to 1.6 grams of protein per kilogram of body weight daily to optimize muscle synthesis .(CU Anschutz News, eucalyptus.health)

Additionally, mindful eating practices can mitigate gastrointestinal side effects associated with GLP-1s, enhancing adherence and comfort .(PMC)

5. GLP-1s Offer Benefits Beyond Weight Loss

Beyond facilitating weight reduction, GLP-1 receptor agonists have been linked to improved cardiovascular health. They can lower blood pressure, improve lipid profiles, and reduce inflammation, contributing to decreased cardiovascular risk .(AHA Journals)

These systemic benefits highlight the multifaceted advantages of GLP-1 therapy when integrated with comprehensive health strategies.

6. Behavioral Support Enhances Outcomes

Incorporating behavioral coaching alongside GLP-1 treatment can bolster weight loss efforts. A study indicated that participants receiving health and well-being coaching in addition to GLP-1 therapy achieved better weight maintenance and body composition outcomes .(PMC)

Such support systems address psychological and lifestyle factors, fostering long-term adherence and success.(The Guardian)

7. Santa Cruz CORE: Your Partner in Holistic Health

At Santa Cruz CORE, we recognize that effective weight management extends beyond medication. Our integrated approach combines medical oversight with personalized fitness programs, nutritional counseling, and behavioral support.

Our team collaborates with clients to develop sustainable lifestyle changes, ensuring that the benefits of GLP-1 therapy are maximized and maintained. By addressing the physical, nutritional, and psychological aspects of health, we empower individuals to achieve lasting wellness.

Conclusion

GLP-1 receptor agonists represent a significant advancement in weight management and metabolic health. However, their efficacy is greatly enhanced when paired with regular exercise, balanced nutrition, and behavioral support. By embracing a holistic approach, individuals can not only achieve weight loss but also sustain it, improving overall health and quality of life.(Diabetes Journals)

References

Wong, H. J., et al. (2025). Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials. Diabetes Care, 48(2), 292–300. https://diabetesjournals.org/care/article/48/2/292/157724/Efficacy-of-GLP-1-Receptor-Agonists-on-Weight-Loss(Diabetes Journals)
Health and Wellness CU Anschutz. (n.d.). The Crucial Role of Balanced Nutrition and Exercise with Weight Loss Medications. https://news.cuanschutz.edu/health-and-wellness/the-crucial-role-of-balanced-nutrition-and-exercise-with-weight-loss-medications(CU Anschutz News)
Health.com. (n.d.). GLP-1s and Exercise: How and Why To Combine the Two. https://www.health.com/glp-1s-and-exercise-8671306(Health)
The Guardian. (2025, May 14). People who stop weight loss drugs return to original weight within year, analysis finds. https://www.theguardian.com/society/2025/may/14/people-who-stop-weight-loss-drugs-return-to-original-weight-within-year-analysis-finds(The Guardian)
Eucalyptus Health. (n.d.). Losing weight on GLP-1s – Why the medication alone isn’t enough. https://www.eucalyptus.health/blog/why-the-medication-alone-isnt-enough(eucalyptus.health)
PubMed. (n.d.). Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial. https://pubmed.ncbi.nlm.nih.gov/36841762/(PubMed)
PMC. (n.d.). Endurance Training Improves GLP-1 Sensitivity and Glucose Tolerance in Overweight Women. https://pmc.ncbi.nlm.nih.gov/articles/PMC9351379/(PMC)
Circulation Research. (n.d.). Treatment of Obesity in Mitigating Metabolic Risk. https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.119.315897(AHA Journals)
PMC. (n.d.). Health and Well-Being Coaching Adjuvant to GLP-1 Induced Weight Loss. https://pmc.ncbi.nlm.nih.gov/articles/PMC11577329/(PMC)